Melatech - About the company
Melatech is a seed company based in Copenhagen (Denmark), founded in 2018 by Niels Kvorning Ternov and Niels Steen Krogh. It operates as an AI-based patient treatment management tool for providers. Melatech has raised $574K in funding from Accelerace, with a current valuation of $*****. The company has 16 active competitors, including 4 funded and 2 that have exited. Its top competitors include companies like VieCure, BostonGene and Syapse.
Company Details
AI-based patient treatment management tool for providers. The company provides software solutions to improve patient treatment through optimized clinical workflows. The also offers AI-augmented simulation training, clinical feedback, and management in skin cancer diagnostics.
- Website
- melatech.io
- Email ID
- *****@melatech.io
- Registered Address
- 55, Gammel Køge Landevej, Valby, 2500
Key Metrics
Founded Year
2018
Location
Copenhagen, Denmark
Stage
Seed
Total Funding
$574K in 2 rounds
Latest Funding Round
Investors
Ranked
6th among 16 active competitors
Annual Revenue
$0 - $1M as on Dec 31, 2019
Employee Count
29 as on May 31, 2026
Legal entities associated with Melatech
Melatech is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MelaTech ApS CIN: 39767317 , Denmark, Active | Aug 06, 2018 | $0 - $1M (As on Dec 31, 2019) | - | |
MelaTech IVS CIN: 39767317 , Denmark, Active | Aug 06, 2018 | - | 31 (As on Nov 30, 2024) |
Sign up to download Melatech's company profile
Melatech's funding and investors
Melatech has raised a total funding of $574K over 2 rounds. Its first funding round was on 2022. Its latest funding round was a Seed round on Nov 30, 2022 for $*****. 1 investor participated in its latest round. Melatech has 1 institutional investor and 2 angel investors.
Here is the list of recent funding rounds of Melatech:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 30, 2022 | 1904325 | Seed | 8990430 | 8513098 | 7399560 | 2242496 |
2022 | 7201 | Seed | 4894 | 5134 | 8840 |
Access funding benchmarks and valuations. Sign up today!View details of Melatech's funding rounds and investors
Melatech's founders and board of directors
Founder? Claim ProfileThe founders of Melatech are Niels Kvorning Ternov and Niels Steen Krogh. Niels Kvorning Ternov is the CEO of Melatech.
Here are the details of Melatech's key team members:
- Niels Kvorning Ternov: Co-Founder & CEO of Melatech.
- Niels Steen Krogh: Co-Founder of Melatech.
View details of Melatech's Founder profiles and Board Members
Melatech's employee count trend
Melatech has 29 employees as of May 26. Here is Melatech's employee count trend over the years:
Uncover Melatech's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Melatech's Competitors and alternates
Top competitors of Melatech include VieCure, BostonGene and Syapse. Here is the list of Top 10 competitors of Melatech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | VieCure 2015, Greenwood Village (United States), Series C | AI-based platform for generating oncology treatment plans | $113M | 63/100 | |
2nd |  BostonGene 2015, Waltham (United States), Series B | Developer of cloud-based information and analytics platform to treat cancer | $200M | 57/100 | |
3rd | Syapse 2008, San Francisco (United States), Acquired | Developer of precision medicine for the treatment of cancer | $223M | 54/100 | |
4th | Oncospace 2018, Baltimore (United States), Acquired | Provider of healthcare solutions focused on cancer patients | $900K | 39/100 | |
5th |  OncoRx Insights 2022, Boulder (United States), Unfunded | Provider of radical new insights and solutions for oncologists and patients in the healthcare industry | - | - | 28/100 |
6th | AI-based patient treatment management tool for providers | $574K | 28/100 | ||
7th |  PersonaDx 2022, Chicago (United States), Unfunded | Provider of a platform for diagnosis and treatment of cancer through blood-based biomarker tests | - | - | 25/100 |
8th |  Curenetics London (United Kingdom), Unfunded | Cloud and AI-based cancer care planning platform for professionals | - | - | 24/100 |
9th |  Iakan Health 2019, Valencia (Spain), Funding Raised | Provider of an AI-based decision support platform for personalized cancer treatment | - | 23/100 | |
10th | Kuveda 2013, San Jose (United States), Seed | Provider of SaaS tools for analysis of cancer patients molecular profiles | $70K | 22/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Melatech's competitors? Click here to see the top ones
Melatech's Investments and acquisitions
Melatech has made no investments or acquisitions yet.
Reports related to Melatech
Here is the latest report on Melatech's sector:
Are you a Founder ?
FAQs about Melatech
Explore our recently published companies
- Kela - 2024 founded, Funding Raised company
- BHI - New York City based, 2026 founded, Unfunded company
- Sherwood Crown Investment - Nottingham based, 2024 founded, Unfunded company
- Roman Tiles - London based, 2019 founded, Unfunded company
- Fox59 - 1996 founded, Unfunded company
- Kfor - 1995 founded, Unfunded company
